A Validated RP - HPLC Method for Simulataneous Estimation of Lamivudine and Tenofovir Disoproxil Fumarate in Pure and in Tablet Dosage Form
 
More details
Hide details
1
Department of Pharmaceutical Analysis, Adhiparasakthi College of Pharmacy, Melmaruvathur - 603 319. Kanchipuram (D.T), Tamil Nadu, India
2
Department of Pharmacy, Annamalai University, Annamalai Nagar - 608 002, Tamil Nadu, India
CORRESPONDING AUTHOR
Anandakumar Karunakaran   

Department of Pharmaceutical Analysis, Adhiparasakthi College of Pharmacy, Melmaruvathur - 603 319. Kanchipuram (D.T), Tamil Nadu, India
Publication date: 2017-10-20
 
Eurasian J Anal Chem 2012;7(2):56–66
 
KEYWORDS
ABSTRACT
A simple, rapid reverse - phase high performance liquid chromatographic method has been developed and validated for the simultaneous estimation of lamivudine and tenofovir disoproxil fumarate in pure and in tablet dosage form. The estimation was carried out on a Phenomenax Luna C18 (150 mm x 4.6 mm i.d., particle size 5μm) column with a mixture of acetonitrile: methanol: water in the ratio of 30:50:20 (v/v) as mobile phase. UV detection was performed at 258 nm. The method was validated for linearity, accuracy, precision, specificity and sensitivity as per ICH norms. The developed and validated method was successfully used for the quantitative analysis of commercially available dosage form. The retention time was 3.27 and 4.15 min. for lamivudine and tenofovir disoproxil fumarate, respectively. The flow rate was 1.0 mL min-1. The calibration curve was linear over the concentration range of 2 –12 μg mL-1 for both lamivudine and tenofovir disoproxil fumarate. The LOD and LOQ values were found to be 0.0099 and 0.0299 μg mL-1 for lamivudine and 0.0328 and 0.0994 μg mL-1 for tenofovir disoproxil fumarate, respectively. The high percentage of recovery and low percentage coefficient of variance confirm the suitability of the method for the simultaneous estimation of lamivudine and tenofovir disoproxil fumarate in pure and in tablet dosage form.
 
REFERENCES (47)
1.
Budawari S (2006) The Merck Index, 14th Edition, Merck and Co. Inc. Whitehouse Station. NJ, p 927’ 1573.
 
2.
Martindale (2005) The Complete Drug Reference, 34 th Edition, Pharmaceutical Press, London, p 648, 655.
 
3.
Rang H W Dale M M, Ritter J M and Moore P K (2005) Pharmacolgy, 5 th Edition, Churchill Livingstone, Edinburgh, p 660.
 
4.
Indian Pharmacopoeia (2007), Volume II, The Indian Pharmacopoeia Commision, Ghaziabad, p 1276.
 
5.
British Pharmacopoeia (2009), Volume I and II, The Stationary Office, British Pharmacopoeia Commission, UK, p 3407.
 
6.
United States of Pharmacopoeia (2009), Volume II, United States Pharmacopoeial Convention, Rockville, MD, p 2747.
 
7.
Indian Pharmacopoeia (2007), The Indian Pharmacopoeia Commision, Ghaziabad, Volume III, p 1782 – 1783.
 
8.
Shirkhedkar A A, Bhirud C H, Surana S J (2009) Application of UVSpectrophotometric Methods for Estimation of Tenofovir Disoproxil Fumarate in Tablets. Pak J Pharm Sci 22(1): 27-29.
 
9.
Sparidans R W, Crommentuyn K M, Schellens J H, Beijnen J H (2003) Liquid-Chromatography assay for the antiviral nucleotide analogue tenofovir in plasma using derivitization with chloroacetaldehyde. J Chromatogr B 791: 227-33.
 
10.
Sentenac S, Fernandez C, Thuillier A, Lechat P and Aymard G (2003) Sensitive determination of tenofovir in human plasma samples using reversed-phase liquidchromatography. J Chromatogr B 793(2): 317-24.
 
11.
Kandagal P B, Manjunatha D H, Seetharamappa J and Kalanur S S (2008) RP-HPLC method for the determination of tenofovir in pharmaceutical formulations and spiked human plasma. Anal Lett 41(4): 561-70.
 
12.
Delahunty T, Bushman L, Fletcher C V (2006) Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS. J Chromatogr B 830: 6-12.
 
13.
Massaki T, Yuichi K, Naoya O, Atsushi H, Kazuhide B, Tsuguhiro K (2007) Determination of plasma tenofovir concentration using a conventional LC-MS method. Biol Pharm Bull 30: 1784-86.
 
14.
King T, Bushman L, Kiser J, Anderson P L, Michelle R, Delahunty T and Fletcher C V (2006) Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. J Chromato B 843(2,7): 147-56.
 
15.
Marc Schuman, Serge Schneider,Christine Omes, Robert Wennig, Leon Fundira, Jean-Claude Tayari and Vic Arendt (2005) HPLC analysis of generic antiretroviral drugs purchased in Rwanda. Bull Soc Sci Med 3: 317 – 325.
 
16.
Basavaiah K and Somashekar B C (2006) Titrimetric and Spectrophotometric methods for the assay of Lamivudine in Pharmaceuticals. J Sci Ind Res 65: 349 – 354.
 
17.
Basavaiah K, Somashekar B C and Ramakrishna V (2007) Rapid titrimetric and spectrophotometric assay methods for the determination of lamivudine in Pharmaceuticals using iodate and two dyes. J Anal Chem 62 (6): 542 – 548.
 
18.
Gholamreza Bahrami, Shahla Mirzaeei, Amir Kiani and Bahareh Mohammadi (2005) High-performance liquid chromatographic determination of lamivudine in human serum using liquid–liquid extraction; application to pharmacokinetic studies. J Chromatogr B 823 (2): 213 – 217.
 
19.
Sibel A, OzkanBengi and Uslu (2002) Rapid HPLC Assay for Lamivudine in Pharmaceuticals and Human Serum. J Liq Chromatogr and Rel Tech 25 (9): 1447-1456.
 
20.
Eunice Kazue Kano, Cristina Helena dos Reis Serra, Eunice Emiko Mori Koono and Simone Schramm (2006) Determination of lamivudine in human plasma by HPLC and its use in bioequivalence studies. J Pharm Biomed Anal 4 (3): 761 – 765.
 
21.
Mangoankar K and Desai A (2008) Simultaneous estimation of emtricitabine, tenofovir disoproxil fumarate and efavirenz from tablets by reverse phase highperformance liquid chromatography method. Indian Drugs 45(3): 188-92.
 
22.
Appala N R, Rao V J, Vanitha P K, Mukilteo K and Srinivasu K (2008) Simultaneous estimation of tenofovir disoproxil, emtricitabine and efavirenz in tablet dosage form by RP- HPLC. Orient J Chem 24(2): in press.
 
23.
Raju N A, Begum S (2008) Simultaneous RP-HPLC Method for the Estimation of theEmtricitabine, Tenofovir Disoproxil fumarate and Efavirenz in Tablet Dosage form. Research J Pharm and Tech 1(4):522-25.
 
24.
Unnam S, Bodepudi H, Kottapalli C B (2007) Development and Validation of Stability indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substances. J Sep Sci 30: 999-1004.
 
25.
Rezk N L , Crutchley R D , Kashuba A D M ( 2005) Simultaneous quantification of emtricitabine and tenofovir in human plasma using high performance liquid chromatography after solid phase extraction. J Chromatogr B 822: 201-8.
 
26.
Gomes N A, Vaidya V V, Pudage A, Joshi S S and Parekh S A (2008) Liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. J Pharm Biomed Anal 48(3): 918-26.
 
27.
V.P. Devmurari (2010) Simultaneous Spectrophotometric Determination of Lamivudine and Abacavir in the Mixture. Int J Pharm Sci and Res 1 (7): 82 – 86.
 
28.
Devyani dube and Vyas S P (2009) Simultaneous Spectrophotometric Estimation of Lamivudine and Silymarin in Mixture. Int J Pharmacy and Pharm Sci 1 (2): 107 – 111.
 
29.
Abd El-Maaboud I.Mohamed and Workalemahu Mikre (2009) Determination of Lamivudine and Stavudine in Pharmaceutical Preparations using Chemometrics-Assisted Spectrophotometry. Saudhi Pharm J 17 (4): 286 – 293.
 
30.
Namita Kapoor, Sateesh Khandavilli and Ramesh Panchagnula (2006) Simultaneous determination of lamivudine and stavudine in antiretroviral fixed dose combinations by first derivative spectrophotometry and high performance liquid chromatography. J Pharm Biomed Anal 3 (7): 761 – 765.
 
31.
Nagulwar V and Bhusari K (2009) First order derivative spectrophotometric method for simultaneous estimation of lamivudine, nevirapine and zidovudine in tablets. Asian J Chem 21 (16): 4689 – 4693.
 
32.
Sarkar Mahua, Khandavilli Sateesh and Panchagnula Ramesh (2006) Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms. J Chromatogr B 830 (2): 349 – 354.
 
33.
Anantha Kumar D, Srinivasa Rao G and Seshagiri Rao J V L N (2010) Simultaneous Determination of Lamivudine, Zidovudine and Abacavir in Tablet Dosage Forms by RP HPLC Method. E J Chem 7(1): 180 184.
 
34.
Anantha Kumar D, Naveen Babu M V , Seshagiri Rao J V L N and Jayathirtha Rao V (2010) Simultaneous Determination of Lamivudine, Zidovudine and Nevirapine in Tablet Dosageforms by RP-HPLC Method. 3 (1): 94 – 99.
 
35.
Jayakar B, Kumar M, Saravanan C and Kumudhavalli M V (2010) Method Development and Validation of RP-HPLC Method for Simultaneous Determination of Lamivudine and Zidovudine. J Chem Pharm Res 2 (1): 478 – 481.
 
36.
Weerasak Samee, Paron Srilamai, Sasithorn Ongart, Ritthichai Suwannaratana, Chayanid Sornchaithawatwong and Suwanna Vorarat (2007) Simultaneous Determination of Lamivudine, Stavudine and Nevirapine in the Presence of Their Acid-Induced Degradation Products by HPLC. Thai Pharm Health Sci J 2 (1): 39 – 45.
 
37.
Pai N, Desai AD (2007) Simultaneous reverse phase HPLC estimation of some antiretroviral drugs from tablets. Indian J Pharm Sci 69:118-20.
 
38.
Saka C (2009) High-performance liquid chromatography methods to simultaneous determination of anti-retroviral drugs in biological matrices. Critical Rev Anal Chem 39 (2): 108 – 125.
 
39.
Abhinav Garg, Love Kumar Soni1, Satish G. Kaskhedikar, Kona S. Srinivas, Loveraj Singh, Kamal K. Gupta and Dhananjay Dwivedi (2009) Development and Validation of HPLC Method for Analysis of some Antiretroviral agents in their Pharmaceutical dosage forms 43 (6): 369 – 374.
 
40.
Kenney KB, Wring SA, Carr RM, Wells GN and Dunn JA (2000) Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry. J Pharm Biomed Anal 22 (6): 967 – 983.
 
41.
Maithilee Joshi A P, Nikalje M, Shahed, and Dehghan M (2009) HPTLC Method for the Simultaneous Estimation of Emtricitabine and Tenofovir in Tablet Dosage Form. Indian J Pharm Sci 71 (1): 95 – 97.
 
42.
Anbazhagan S, Indumathy N, Shanmugapandiyan P and Sridhar S K (2005) Simultaneous quantification of stavudine, lamivudine and nevirapine by UV spectroscopy, reverse phase HPLC and HPTLC in tablets. J Pharm Biomed Anal 39 (3-4): 801 – 804.
 
43.
Stephen Kewn, Patrick G. Hoggard, Sean D. Sales, Kevin Jones, Bridget Maher, Saye H. Khoo and David J. Back (2002) Development of Enzymatic Assays for Quantification of Intracellular Lamivudine and Carbovir Triphosphate Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy 46 (1): 135 – 143.
 
44.
Eugenia Soboleva and Arpad Ambrus (2004) Application of system suitability test for quality assurance and performance optimization of a gas chromatographic system for pesticide residue analysis. J Chromatogr A 1027: 55 – 65.
 
45.
Osman Tiryaki, Dilan Baysoyu, Gulizar Aydin, Emine Secer (2009) Setting system suitability parameters for performance optimization of GC – NPD detection for pesticide residue analysis. GU J Sci 22(3): 149 – 155.
 
46.
International Conference on Harmonization. ICH Harmonised Tripartite Guidelines–Validation of Analytical Procedures: Methodology, (1997) Q2A and Q2B.
 
47.
Osman Tiryaki (2006) Method validation for the analysis of pesticide residues in grain by thin layer chromatography. Accred Qual Assur 11: 506 – 513.
 
eISSN:1306-3057